Neuboron Medical Group

Neuboron Medical Group is a pioneering healthcare company specializing in the development of Accelerator-based Boron Neutron Capture Therapy (AB-BNCT) systems and associated boron-containing pharmaceuticals. The company provides a comprehensive total solution for BNCT, integrating high-intensity neutron sources, precision treatment planning software, and targeted boron-10 delivery agents. Neuboron's technology is designed to offer cell-level precision radiotherapy for refractory and recurrent tumors, such as glioblastoma and advanced head and neck cancers, which are often resistant to conventional treatments. Headquartered in China, the group has successfully established clinical BNCT centers and is advancing its integrated platform through multi-center clinical trials.